Drug intelligence / Profile preview

Sonomedin

Development stage
Unknown
Lead developer
NutriMed Group
Modality
Small Molecules
Administration
Oral
01

Overview

Sonomedin is a multi-ingredient nutraceutical product developed by NutriMed Group, primarily indicated for the management of sleep disorders and the normalization of circadian rhythms. Its formulation typically combines melatonin, L-theanine, and valerian extract. Melatonin serves as an exogenous agonist for MT1 and MT2 receptors in the suprachiasmatic nucleus, mimicking the natural hormone to regulate the sleep-wake cycle. L-theanine, an amino acid found in tea, and valerian extract work synergistically to promote relaxation and reduce sleep latency by modulating the GABAergic system, specifically increasing inhibitory neurotransmission. This combination is used to address insomnia, improve sleep quality, and mitigate the effects of jet lag or shift work.

Brand names
Sonomedin
Other names
Сономедин
02

Targets

GABAA (Gamma-aminobutyric acid receptor)MTNR1B (Melatonin Receptor 2)MTNR1A (MT1)

Beyond the preview

Go deeper on Sonomedin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sonomedin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call